Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Leukemia & Lymphoma

Font Size

Experimental Drug Works in Chronic Leukemia

WebMD Health News

April 4, 2000 (San Francisco) -- Doctors say an experimental drug that showed extraordinary early success in controlling leukemia may also work in a rare but lethal brain cancer, and in a form of lung cancer.

Known under its research name of STI571, the drug, taken by mouth, is designed to interfere with a key substance in the body that is required for development of chronic myelogenous leukemia (CML). CML is a blood disease that strikes 4,500 people in the U.S. each year in which the body overproduces white blood cells. About a third of the people are candidates for bone marrow transplants, while the rest have to rely on the drug interferon. From time of diagnosis, the average person will die within four to six years.

But for patients participating in the STI571 studies, their white blood cells returned to normal levels if they were taking appropriate amounts of the drug -- about four tablets once a day, according to lead researcher Brian Druker, MD. Druker, associate professor of medicine at the Oregon Health Sciences University in Portland, presented his findings at a meeting of cancer researchers here.

"The patients are still taking the medication, about eight to 10 months later, because if we look closely in their bone marrow, we can still see evidence of the leukemia," Druker tells WebMD. The patients entered into the study had been diagnosed with CML for an average of three and a half years.

Druker explained that STI571 is designed to halt the disease from progressing. He said the pill also appears to be effective against a brain cancer called glioblastoma, and for small cell lung cancer as well.

"We are really witnessing an enormous payoff of the Unites States investment in cancer research," said William Hait, MD, director of the Cancer Institute of New Jersey in New Brunswick. "It is uncommon to see this kind of response in [the early stages of a] clinical trial. To see even a 25% response rate would be great. Because all these patients have been extensively treated with other medication, the hurdle is set very high to see a response ... These results are extraordinary."

Today on WebMD

stem cells
What are they and why do we need them?
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
Vitamin D
New Treatments For Non-Hodgkins Lymphoma
Lifestyle Tips for Depression Slideshow
Pets Improve Your Health